InSitu Biologics has had a very productive summer. We received positive pre-clinical animal study results on our lead product, had positive regulatory interactions with the FDA, further developed our manufacturing capabilities, and made progress towards future funding of the Company.

For additional information regarding our progress, please take some time to read our company update.

CEO Update August 2021